David Humphrey is recorded as Head of Investor Relations at Arcbest Corp (ARCB) and CFO at Ensysce Biosciences, Inc. (ENSC). The newest filing on record that lists David Humphrey as CFO at Ensysce Biosciences, Inc. (ENSC) is dated November 12, 2026. Earlier roles on record: Board Member at Nutanix, Inc. (NTNX) until May 15, 2025. Nutanix, Inc. reported in an 8-K filed June 16, 2025 that David Humphrey resigned as board of directors, effective May 15, 2025. Nutanix, Inc. reported in an 8-K filed May 16, 2025 that David Humphrey resigned as director, effective May 15, 2025. David Humphrey has spoken on 16 earnings calls across 1 company, most recently for Arcbest Corp on April 30, 2024. Arcbest Corp is classified in the Trucking industry within the Industrials sector. Ensysce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcbest Corp includes Judy McReynolds (CEO and Board Member), Judy R. McReynolds (CEO), Seth Runser (CEO, COO and Board Member) and 7 others.
“Additionally, David Humphrey resigned from Nutanix's board of directors, effective May 15, 2025.”
Nutanix, Inc. Form 8-K, filed June 16, 2025
· Read the filing
“On May 13, 2025, David Humphrey submitted his resignation as a director, effective as of May 15, 2025.”
Nutanix, Inc. Form 8-K, filed May 16, 2025
· Read the filing
David Humphrey on recent calls
“Today, we'll provide an update on our business, walk you through the details of our recent first quarter 2024 results and then answer some questions.”
“On today's call we'll provide an update on our business, walk you through the details of our recent fourth quarter and full year 2023 results, and then answer some questions.”
“On today's call, we’ll provide an update on our business, walk you through the details of our recent second quarter 2023 results, and then answer some questions.”
“On today's call, we will provide an update on our business, walk you through the details of our recent first quarter 2023 results and then answer some questions.”
